4.37 USD
▲+0.23+0.69%
盘后 4.23 -2.53%
2026-08-03
市值
$2.32M
市盈率
—
EPS
-57.12
股息率
—
52 周区间
3.51 – 120.60
成交量
35.76K
Beta
0.58
目标价
—
52W 低 3.5152W 高 120.60
价格走势
公司简介
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverages peptide coiled-coils chemistry and physics to design α-helical peptides through computational and ML tools. The company’s IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, enhance, and manufacture peptide conjugates targeting ...